Glucosamine Linked to Faster Alzheimer’s Progression in Patients with Mild Cognitive Impairment

1. University of Florida researchers found that glucosamine, the popular joint supplement taken by tens of millions of older Americans, is associated with a 25% higher likelihood of progressing from mild cognitive impairment to Alzheimer’s disease. 2. The proposed mechanism is biochemically plausible: glucosamine is a sugar-related molecule that crosses the blood-brain barrier and appears […] The…